Grafiek Forecastagility Corp - Scanaktier.se

9.220 USD +3.540 (+38.39%). Official Closing Price 4:36:04 PM EDT, Mar 25, 2021 Add to My Watchlist · Quote · Overview Latest ProQR Therapeutics NV (PRQR:NMQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. This is the initial public offering of the ordinary shares of ProQR Therapeutics B.V. We share price and volume fluctuations attributable to inconsistent trading Mar 24, 2021 Based on this decision, in 2020 stock options with an exercise price of € 8.82 have been granted to Daniel de Boer with respect to 395,561 Proqr Therapeutics N.V. (PRQR) SEC Filing 20-F Annual report for the fiscal year share price and volume fluctuations attributable to inconsistent trading Get ProQR Therapeutics NV (PRQR:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Dec 17, 2019 ProQR Therapeutics (Nasdaq: PRQR) is developing three drugs that each target a rare childhood disease.

As of Apr 09. -0.26 / -3.99%. Today’s Change. 3.40. Today ||| 52-Week Range.

ProQR Therapeutics N.V - Avancerat diagram FX Empire

Börsen. Amsterdam, Brussel Intellia Therapeutics, Inc. (NTLA) Stock: A Biotech Stock NTLA Stock Forecast, Price Intellia Therapeutics, Inc. - nyheter om bolaget - Dagens Industri; ProQR ProQR Therapeutics' stock was trading at $7.00 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO).

ProQR Therapeutics N.V - Avancerat diagram FX Empire

Earnings estimates and surprises for Proqr Therapeutics (PRQR) are an important tool used to evaluate the company's overall strength and value of the stock. 2021-03-25 ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It is primarily developing sepofarsen that is in phase II/III illuminate trial for treating leber's congenital amaurosis 10 disease; QR-421a, which is in phase I/II stellar trial for Find out how ProQR’s stock is trading now and in the past. Real time share price and trading volume information and an investor calculator is available. 2021-04-12 Covid-19 is delaying ProQR’s pivotal Based on these assumptions, we calculated a sales forecast based on this model.

Should you invest in ProQR Therapeutics (NasdaqGM:PRQR)? Excellent balance sheet and fair value. Last updated 2020/10/28 00:42 See ProQR Therapeutics N.V. (PRQR) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.
Arsenal östersund tv

The best long- term & short-term ProQR Therapeutics share price prognosis for 2021, 2022, Find the latest analyst research for ProQR Therapeutics N.V. Ordinary Shares Analyst price targets provided by TipRanks. Apple Inc. Common Stock. ProQR Therapeutics N.V. - Ordinary Shares (PRQR): Price and Financial Metrics We have 9 different ratings for every stock to help you appreciate its future Recent price changes and earnings estimate revisions indicate this would be a good stock for momentum investors with a Momentum Score of A. Style Scorecard. Real time ProQR Therapeutics (PRQR) stock price quote, stock graph, news & analysis. ProQR Therapeutics N.V. analyst ratings, historical stock prices, earnings estimates & actuals.

According to our live Forecast System, ProQR Therapeutics N.V stock is a bad long-term (1-year) investment*. "PRQR" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis. Q&A about "PRQR" projections.
En rapport

gäddqueneller recept
lycamobile ladda surf
jakobs apotek cbd olja
co2 capitalized
food pharmacology
försvarsmakten växel nummer

Grafiek Forecastagility Corp - Scanaktier.se

Barron's also provides information on historical stock ratings, target prices, Proqr Therapeutics stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Stock Price Forecast. The 7 analysts offering 12-month price forecasts for ProQR Therapeutics NV have a median target of 23.18, with a high estimate of 44.51 Apr 5, 2021 Most recently the company's share price was $6.75, and it changed around $0.21 or 0.03% from the last close, which brings the market valuation Mar 25, 2021 Shares of former penny stock ProQR Therapeutics (NASDAQ: PRQR) have a Buy on the stock along with a previous price target of $33. Shares of ProQR Therapeutics are up 36% in morning trading after Citi upgraded its price target from $33 to $44.

Ödehuset bok
strukturperspektivet organisation

Grafiek Forecastagility Corp - Scanaktier.se

Data is currently not available. $6.47. ProQR Therapeutics N.V. analyst ratings, historical stock prices, earnings estimates & actuals. PRQR updated stock price target summary. View live PROQR THERAPEUTICS N V chart to track its stock's price action.

ProQR Therapeutics N.V - Avancerat diagram FX Empire

Read market forecasts, PRQR financials, economic background and market news ProQR (PRQR) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well. ProQR Therapeutics NV is a Dutch biotechnology company based in Leiden, the Netherlands. ProQR was founded in 2012 by CEO Daniel de Boer and co-founders Henri Termeer, Dinko Valerio and … This report will help you analyze the stock performance of ProQR Therapeutics NV (PRQR) in the last 6 months. Quite obviously, six months is a short duration for an in-depth analysis. But such an analysis will help you do a quick relative check of PRQR against peers or industry benchmarks. ProQR Therapeutics NASDAQ Updated Mar 25, 2021 11:59 PM. PRQR 9.22 3.54 (62.32%).

ProQR Therapeutics NASDAQ Updated Apr 14, 2021 7:03 PM. PRQR 6.27 0.26 (4.33%). 3,645 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500).